The pharmaceutical landscape is seeing a development with the arrival of GLP-1 patches . These cutting-edge formulations offer a possible alternative to providing glucagon-like peptide-1 therapies for individuals living with hyperglycemia. Instead of daily shots , a convenient patch affixed to the body could administer a steady quantity of the zepb